Cargando…
Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage
The identification of an agent effective for the treatment of intestinal and bone marrow injury following radiation exposure remains a major issue in radiological medicine. In this study, we evaluated the therapeutic impact of single agent or combination treatments with 2-(3-aminopropylamino) ethyls...
Autores principales: | Liu, Wei, Chen, Qiu, Wu, Shu, Xia, Xiaochun, Wu, Anqing, Cui, Fengmei, Gu, Yong-ping, Zhang, Xueguang, Cao, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380048/ https://www.ncbi.nlm.nih.gov/pubmed/25617317 http://dx.doi.org/10.1093/jrr/rru100 |
Ejemplares similares
-
Antiretroviral activity of aminothiols, WR2721 and WR1065
por: Poirier, Miriam C, et al.
Publicado: (2006) -
Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.
por: Durand, R. E., et al.
Publicado: (1989) -
Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
por: Twentyman, P. R.
Publicado: (1981) -
A more general role for WR-2721 in cancer therapy.
por: Yuhas, J. M.
Publicado: (1980) -
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
por: Rojas, A., et al.
Publicado: (1983)